Document Classification

Section Type: RESULTS

Text: A total of 342 patients received irinotecan-based chemotherapy as second-line chemotherapy : FOLFIRI-3 [n = 109, irinotecan 100 mg/m (2) days 1 and 3 combined with leucovorin (LV) 400 mg/m (2) day 1 and 46-h continuous 5-fluorouracil (5-FU) 2000 mg/m (2)], FOLFIRI-1 (n = 112, irinotecan 180 mg/m (2) day 1 combined with LV 400 mg/m (2) day 1, 5-FU bolus 400 mg/m (2) and 46-h continuous 5-FU 2400 mg/m (2)) and other various irinotecan-based regimens (n = 121).